Airway Therapeutics Raises $50 Million to Advance Zelpultide Alfa Clinical Program

Airway Therapeutics has closed a $50 million equity financing round to fund late-stage development of zelpultide alfa, its lead biologic... Read More

The post Airway Therapeutics Raises $50 Million to Advance Zelpultide Alfa Clinical Program appeared first on citybiz.